PROM1 and malignant colon neoplasm: In this study, we for the first time developed real time PCR for CD44v8-v10 as the most optimal representative for CD44V expression together with CD44T expression and an emerging stem cell marker CD133 in primary colon tumors, because such differential quantitative assessments have never been done in primary colon cancer.